Our trust values
University Hospitals Dorset NHS Foundation Trust
cleat recruitment progress

What is the CLEAT study

cleat

CLEAT is a research study for people with hip arthritis who have been referred to the physiotherapy department at University Hospitals Dorset. We need 256 patients to complete the study.

The purpose of the study is to find out whether people who receive a group 8-week education and static cycling treatment (The CHAIN programme) have an improvement in their hip function and less pain than those patients who receive usual physiotherapy treatment within the NHS.

It is delivered in Bournemouth, Dorset (UK) by University Hospitals Dorset and involves researchers from Bournemouth University.

Half of patients on the study will receive routine physiotherapy treatment that is available through the NHS. The other half will receive group education and static cycling sessions (The CHAIN programme) for one hour per week over eight weeks at the Littledown Centre in Bournemouth.

Whether you receive standard physiotherapy treatment or the weekly static cycling and education sessions will be decided at random, similar to the toss of a coin.  Your levels of hip function and pain will be assessed at the Orthopaedic Research Institute, Bournemouth University before you start your treatment and again once your treatment has finished so that we can record any changes. We will also send you some further questionnaires to complete three months after you have finished treatment.

The results of this study will be based on your opinions about changes in pain, ability to perform everyday activities and quality of life; and from information collected by the research team at your assessments. 

What are the benefits of taking part in the study?

This research aims to improve patient care. By taking part in this research, you will help to guide treatment for future patients. In addition to your treatment, you will also benefit from a baseline and follow up assessment with a physiotherapist, where you will be able to ask further questions and measure the outcome of your treatment.

Am I suitable for the study?

You may be considered suitableif you are aged 45 years or older, have hip pain or hip arthiritis, and:

  • Haven’t had hip surgery within the last 6 months
  • Are not planning on having lower limb or back surgery in the next 9 months
  • Haven’t used oral or intra-articular corticosteroids in the last 3 months (except for asthma)

You should not take part if you are:

  • Pregnant and not exercising regularly
  • Unable to get on or off a bike.

How can I take part in the CLEAT study?

  1. You can refer yourself
  2. You can be referred by your GP, Consultant, or physiotherapist

If you have hip arthritis and you would like to take part in the study, you can either ask your GP to refer you to physiotherapy at Christchurch Hospital, University Hospitals Dorset, stating that you are interested in taking part in the CLEAT study; or you can self-refer via the Musculoskeletal (MSK) Dorset website https://www.mskdorset.nhs.uk/patient-self-referral-form/, again stating that you would like to take part in the CLEAT study.

How can GPs and other clinicians refer patients to the CLEAT study?

Please refer your patients to physiotherapy at Christchurch Hospital, University Hospitals Dorset, stating that they may be suitable for taking part in the CLEAT study.

What happens once I have been referred?

Once we have received your referral, you will be contacted by telephone to discuss the study and check you are suitable to take part. If you choose to take part, you will be invited to attend a baseline assessment at the Orthopaedic Research Institute, Bournemouth University. 

cleat timeline v2

Study research team

Tom Wainwright

Chief Investigator: Professor Tom Wainwright


Norbert Bokor

Trial Manager: Norbert Bokor


Harriet Legg

Assessor: Tikki Immins


Shay Bahadori

Assessor: Shay Bahadori


Louise Burgess

Assessor: Louise Burgess


Physiotherapist: Harriet Legg

Physiotherapist: Jo Garofalides


Clinical research team

Co-investigator: Professor Robert Middleton

Orthopaedic Specialist Physiotherapist: James Creasey

Physiotherapist: Chris Efford

Physiotherapist: Jo Masterman

Physiotherapist: Liam Johnson

Patient documents

Participant information sheet

Frequently asked questions

Where is the study delivered?

The study is delivered in Bournemouth, Dorset, in England. All assessments take place at the Orthopaedic Research Institute, at Bournemouth University. The CHAIN programme is delivered at the Littledown Centre, opposite The Royal Bournemouth Hospital. Physiotherapy care is delivered at Christchurch Hospital.

class

How do I take part in the study?

Participants are considered for the study if they have been referred to the Physiotherapy Department at University Hospitals Dorset for the treatment of hip pain. Potentially eligible participants will then be contacted by Chief Investigator, Professor Tom Wainwright, to discuss participation within the study.

Can I choose which treatment arm I am in?

No, it is not possible to choose which treatment arm you are in. Treatment arms are allocated randomly using online software. To ensure the study is fair, we cannot let you choose which treatment you receive, or change your treatment arm once it has been allocated. Both treatment arms have proven successful in managing the symptoms of patients with hip osteoarthritis.

Will I be paid for taking part?

You will not be paid for your participation in this study. You will not incur any expenses above that of standard care. All ongoing care that might be required will be provided by the NHS.

Can I withdraw from the study?

You can withdraw from participation in the study at any time without giving a reason. If you withdraw, we will use all of the information that we have collected about you up to that point.

What will happen at the end of the study?

The results from this study will be used to inform and influence decisions around care for hip osteoarthritis in the future. The findings will be published in relevant scientific journals and presented at conferences and meetings. No personal identifiable data will be disclosed in any publication. The results from the study will also be made available on the Orthopaedic Research Institute’s website https://microsites.bournemouth.ac.uk/ori/ and the UHD’s Research and Innovation (R&I) website.

Who is organising and funding the research?

The National Institute for Health Research (NIHR) – Research for Patient Benefit, are funding this study It is organised by the Orthopaedic Research Institute, at Bournemouth University, in collaboration with the Research and Development department at University Hospitals Dorset.

Contact information

Trial Manager: Norbert Bokor

Email: This email address is being protected from spambots. You need JavaScript enabled to view it.

Phone: 01202 961941

Back to top of page